David Delbourgo

David Delbourgo is the CEO and Co-founder of WhiteLab Genomics, an AI-powered genomic medicine platform based in Paris, France. With over 25 years of healthcare innovation experience, he scales medical technology and biotechnology companies through business development and commercial operations. Previously, Delbourgo spent seven years at GE Healthcare advancing cardiovascular imaging technologies and served as Head of Global Marketing and Commercial Operations at Genomic Vision. Under his leadership, WhiteLab Genomics completed the Y Combinator Winter 2022 batch and secured a $10 million Series A funding round in September 2022. He holds an MBA from the University of Chicago Booth School of Business and dual Master's degrees in Biomedical Engineering from the University of Technology of Compiègne and Tel Aviv University. His current focus centers on converging artificial intelligence and life sciences to accelerate therapeutic discovery.